293 related articles for article (PubMed ID: 22018878)
21. Thiosemicarbazones, semicarbazones, dithiocarbazates and hydrazide/hydrazones: anti-Mycobacterium tuberculosis activity and cytotoxicity.
Pavan FR; da S Maia PI; Leite SR; Deflon VM; Batista AA; Sato DN; Franzblau SG; Leite CQ
Eur J Med Chem; 2010 May; 45(5):1898-905. PubMed ID: 20163897
[TBL] [Abstract][Full Text] [Related]
22. Antimycobacterial activity of novel N-(substituted)-2-isonicotinoylhydrazinocarbothioamide endowed with high activity towards isoniazid resistant tuberculosis.
Sriram D; Yogeeswari P; Yelamanchili Priya D
Biomed Pharmacother; 2009 Jan; 63(1):36-9. PubMed ID: 18343086
[TBL] [Abstract][Full Text] [Related]
23. In vitro bactericidal activity of oxazolidinone, RBx 8700 against Mycobacterium tuberculosis and Mycobacterium avium complex.
Rao M; Sood R; Malhotra S; Fatma T; Upadhyay DJ; Rattan A
J Chemother; 2006 Apr; 18(2):144-50. PubMed ID: 16736882
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity.
Martins F; Santos S; Ventura C; Elvas-Leitão R; Santos L; Vitorino S; Reis M; Miranda V; Correia HF; Aires-de-Sousa J; Kovalishyn V; Latino DA; Ramos J; Viveiros M
Eur J Med Chem; 2014 Jun; 81():119-38. PubMed ID: 24836065
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and characterization of novel hydrazide-hydrazones and the study of their structure-antituberculosis activity.
Bedia KK; Elçin O; Seda U; Fatma K; Nathaly S; Sevim R; Dimoglo A
Eur J Med Chem; 2006 Nov; 41(11):1253-61. PubMed ID: 16919372
[TBL] [Abstract][Full Text] [Related]
26. JVA, an isoniazid analogue, is a bioactive compound against a clinical isolate of the Mycobacterium avium complex.
Fahel JS; Vieira RP; Marinho FV; Santos VC; de Assis JV; Corsetti PP; Ferreira RS; de Almeida MV; Oliveira SC
Tuberculosis (Edinb); 2019 Mar; 115():108-112. PubMed ID: 30948164
[TBL] [Abstract][Full Text] [Related]
27. The oriented development of antituberculotics: salicylanilides.
Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Kaustová J; Möllmann U; Dahse HM; Miko M
Arch Pharm (Weinheim); 2006 Nov; 339(11):616-20. PubMed ID: 17048291
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria.
Carroll J; Draper LA; O'Connor PM; Coffey A; Hill C; Ross RP; Cotter PD; O'Mahony J
Int J Antimicrob Agents; 2010 Aug; 36(2):132-6. PubMed ID: 20547041
[TBL] [Abstract][Full Text] [Related]
29. Antitubercular activity of new coumarins.
Cardoso SH; Barreto MB; Lourenço MC; Henriques Md; Candéa AL; Kaiser CR; de Souza MV
Chem Biol Drug Des; 2011 Jun; 77(6):489-93. PubMed ID: 21414146
[TBL] [Abstract][Full Text] [Related]
30. Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors.
Shakya N; Srivastav NC; Bhavanam S; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
Bioorg Med Chem; 2012 Jul; 20(13):4088-97. PubMed ID: 22664188
[TBL] [Abstract][Full Text] [Related]
31. Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies.
Gemma S; Savini L; Altarelli M; Tripaldi P; Chiasserini L; Coccone SS; Kumar V; Camodeca C; Campiani G; Novellino E; Clarizio S; Delogu G; Butini S
Bioorg Med Chem; 2009 Aug; 17(16):6063-72. PubMed ID: 19620006
[TBL] [Abstract][Full Text] [Related]
32. Fullerene isoniazid conjugate--a tuberculostat with increased lipophilicity: synthesis and evaluation of antimycobacterial activity.
Kumar A; Patel G; Menon SK
Chem Biol Drug Des; 2009 May; 73(5):553-7. PubMed ID: 19366360
[TBL] [Abstract][Full Text] [Related]
33. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
Foroumadi A; Soltani F; Moshafi MH
Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384
[TBL] [Abstract][Full Text] [Related]
34. [Drug sensitivity of bacillus strains M. avium-intracellulare (MAIC), M. kansasii cultured from patients with mycobacteriosis before treatment].
Zwolska-Kwiek Z; Augustynowicz-Kopeć E; Zalewska-Schöntaler N
Pneumonol Alergol Pol; 1993; 61(5-6):248-53. PubMed ID: 8348088
[TBL] [Abstract][Full Text] [Related]
35. Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains.
Férriz JM; Vávrová K; Kunc F; Imramovský A; Stolaríková J; Vavríková E; Vinsová J
Bioorg Med Chem; 2010 Feb; 18(3):1054-61. PubMed ID: 20060303
[TBL] [Abstract][Full Text] [Related]
36. Mechanochemical Synthesis and Biological Evaluation of Novel Isoniazid Derivatives with Potent Antitubercular Activity.
Oliveira PFM; Guidetti B; Chamayou A; André-Barrès C; Madacki J; Korduláková J; Mori G; Orena BS; Chiarelli LR; Pasca MR; Lherbet C; Carayon C; Massou S; Baron M; Baltas M
Molecules; 2017 Sep; 22(9):. PubMed ID: 28862683
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and in vitro antimycobacterial activity of 3-substituted 5-hydroxy-5-trifluoro[chloro]methyl-4,5-dihydro-1H-1-(isonicotinoyl) pyrazoles.
Almeida da Silva PE; Ramos DF; Bonacorso HG; de la Iglesia AI; Oliveira MR; Coelho T; Navarini J; Morbidoni HR; Zanatta N; Martins MA
Int J Antimicrob Agents; 2008 Aug; 32(2):139-44. PubMed ID: 18571384
[TBL] [Abstract][Full Text] [Related]
38. Hydrazone, benzohydrazones and isoniazid-acylhydrazones as potential antituberculosis agents.
Sampiron EG; Costacurta GF; Baldin VP; Almeida AL; Ieque AL; Santos NC; Alves-Olher VG; Vandresen F; Gimenes AC; Siqueira VL; Caleffi-Ferracioli KR; Cardoso RF; Scodro RB
Future Microbiol; 2019 Jul; 14():981-994. PubMed ID: 31382801
[No Abstract] [Full Text] [Related]
39. Synthesis and antimycobacterial activity of a novel series of isonicotinylhydrazide derivatives.
Jaju S; Palkar M; Maddi VS; Ronad P; Mamledesai S; Satyanarayana D; Ghatole M
Arch Pharm (Weinheim); 2009 Dec; 342(12):723-31. PubMed ID: 19899098
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo activities of acylated derivatives of isoniazid against mycobacterium tuberculosis.
Hearn MJ; Cynamon MH
Drug Des Discov; 2003; 18(4):103-8. PubMed ID: 15553921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
